However, the issue of estrogen signaling in ovarian cancer might be best examined in the context of subcellular localization of ERα and ERβ in the nucleus and the cytoplasm, resulting in genomic and non-genomic signaling, respectively [181,182]. Here, ESR2 is linked to ovarian cancer.